55th Annual Meeting (October 28-November 2, 2008): Patient Assessed Quality of Life (PQ-LES-Q) vs. Clinician Assessment (PANSS, CGI) in a Trial of Aripiprazole in Adolescent Patients with Schizophrenia

Wednesday, October 29, 2008: 9:15 AM

River Exhibition Hall (Sheraton Chicago Hotel & Towers)

Stephen R. Wisniewski, Ph.D., Epidemiology, University of Pittsburgh, Pittsburgh, PA

Mirza Ali, Ph.D., Otsuka Pharmaceutical Development and Commercialization, Inc., Rockville

Na Jin, M.S., Biostatistics, Otsuka Pharmaceutical Development and Commercialization, Inc., Rockville

Richard Whitehead, B.S., Medical Affairs, Otsuka America Pharmaceutical, Inc., Rockville, MD

Edward Kim, M.D., M.B.A., Health Economics and Outcomes Research, Bristol-Myers Squibb, Plainsboro, NJ

Margaretta Nyilas, M.D., Otsuka Pharmaceutical Development and Commercialization, Inc., Princeton, NJ

William Carson, M.D., Otsuka Pharmaceutical Development and Commercialization, Inc., Princeton, NJ

Taro Iwamoto, Ph.D., Otsuka Pharmaceutical Development and Commercialization, Inc., Princeton, NJ

Andrei Pikalov, M.D., Ph.D., Otsuka America Pharmaceutical, Inc., Rockville, MD

		56th Annual Meeting Tentative Program Schedule
		Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.

New Research Poster Presentation 1.15 Patient Assessed Quality of Life (PQ-LES-Q) vs. Clinician Assessment (PANSS, CGI) in a Trial of Aripiprazole in Adolescent Patients with Schizophrenia